Incretins are changing the narrative of chronic kidney disease
Bariatric surgery in a shot! It might be too effective?! And what's dysesthesia?
Small molecule, flashy results, is it too late to the party?
Orforglipron, HRS 9531, MET-097, Eloralintide and Mazdutide, OH MY!
Less nausea, more insulin sensitivity, and a little less inflammation Part 2 in a series on GIP
The master incretin of the alpha and beta cell starts to shinePart 1 in a series on GIP
Lilly's oral non-peptide GLP-1 could change everything & bimagrumab flexes its muscle, but at what cost?
Novo's Dual Amylin-GLP1 agonist shows promise but caveats apply
